136 related articles for article (PubMed ID: 31274080)
21. Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.
Cao Y; Lu X; Wang J; Zhang H; Liu Z; Xu S; Wang T; Ning S; Xiao B; Wang L
Int J Mol Med; 2017 Feb; 39(2):268-278. PubMed ID: 28075449
[TBL] [Abstract][Full Text] [Related]
22. Special issue: Drug repurposing for cancer therapy.
Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():1-2. PubMed ID: 32679189
[No Abstract] [Full Text] [Related]
23. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
24. Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.
Carrella D; Napolitano F; Rispoli R; Miglietta M; Carissimo A; Cutillo L; Sirci F; Gregoretti F; Di Bernardo D
Bioinformatics; 2014 Jun; 30(12):1787-8. PubMed ID: 24558125
[TBL] [Abstract][Full Text] [Related]
25. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
Zong N; Wong RSN; Ngo V
Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
27. Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Strittmatter SM
Nat Med; 2014 Jun; 20(6):590-1. PubMed ID: 24901567
[No Abstract] [Full Text] [Related]
28. From gene networks to drugs: systems pharmacology approaches for AUD.
Ferguson LB; Harris RA; Mayfield RD
Psychopharmacology (Berl); 2018 Jun; 235(6):1635-1662. PubMed ID: 29497781
[TBL] [Abstract][Full Text] [Related]
29. A review of network-based approaches to drug repositioning.
Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
[TBL] [Abstract][Full Text] [Related]
30. Network-based Drug Repurposing: A Critical Review.
Selvaraj N; Swaroop AK; Nidamanuri BSS; Kumar RR; Natarajan J; Selvaraj J
Curr Drug Res Rev; 2022; 14(2):116-131. PubMed ID: 35156575
[TBL] [Abstract][Full Text] [Related]
31. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
32. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
33. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
Lötsch J; Kringel D
Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
[TBL] [Abstract][Full Text] [Related]
34. Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy.
Gustafson DL; Fowles JS; Brown KC; Theodorescu D
Assay Drug Dev Technol; 2015 Dec; 13(10):623-7. PubMed ID: 26690765
[TBL] [Abstract][Full Text] [Related]
35. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
36. Drug repurposing based on drug-drug interaction.
Zhou B; Wang R; Wu P; Kong DX
Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
[TBL] [Abstract][Full Text] [Related]
37. Metabolic modeling-based drug repurposing in Glioblastoma.
Tomi-Andrino C; Pandele A; Winzer K; King J; Rahman R; Kim DH
Sci Rep; 2022 Jul; 12(1):11189. PubMed ID: 35778411
[TBL] [Abstract][Full Text] [Related]
38. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
Wang H; Gu Q; Wei J; Cao Z; Liu Q
Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
[TBL] [Abstract][Full Text] [Related]
39. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
40. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
